Hair Cortisone Predicts Metabolic Syndrome in Young Adults
Long-term biological stress, measured using hair glucocorticoid levels, was strongly associated with the presence of metabolic syndrome (MetS) and its components such as waist circumference and triglycerides, with the association being particularly pronounced in younger adults for hair cortisone levels.
METHODOLOGY:
Researchers in the Netherlands conducted a cross-sectional study to investigate the relationship between hair glucocorticoid levels and the presence of MetS and its components in 1405 adult participants (median age, 49 years; 73.6% women) from the Netherlands Study of Depression and Anxiety cohort.
Levels of hair glucocorticoids (cortisol and cortisone) were measured using liquid chromatography-tandem mass spectrometry.
Outcomes were the presence of MetS and its individual components that included high-density lipoprotein cholesterol, fasting glucose, and triglyceride levels; diastolic blood pressure; and waist circumference.
This study also assessed whether age (≤ 49 vs ≥ 50 years) modified the relationship between hair glucocorticoids and MetS.
TAKEAWAY:
Hair cortisol (odds ratio [OR], 1.27) and cortisone (OR, 1.32; P < .001 for both) levels were strongly associated with MetS, with the association between hair cortisone and MetS being significantly modified by age (OR, 0.78; P = .003).
< .001 for both) levels were strongly associated with MetS, with the association between hair cortisone and MetS being significantly modified by age (OR, 0.78; = .003). The link between hair glucocorticoids and MetS was stronger in younger participants than in older ones for both hair cortisol (OR, 1.52 vs 1.20) and hair cortisone (OR, 1.95 vs 1.14).
Hair cortisol and cortisone levels were positively correlated with waist circumference ( P < .001 for both) and triglyceride levels ( P < .025 for both); hair cortisol, but not cortisone, levels were also positively associated with diastolic blood pressure ( P = .034) and negatively associated with high-density lipoprotein cholesterol levels ( P = .035).
IN PRACTICE:
"In the future, [the study] findings can be used to identify individuals with increased cardiovascular risk," the authors wrote.
SOURCE:
This study was led by Susanne Kuckuck, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. It was published online on June 03, 2025, in The Journal of Clinical Endocrinology & Metabolism .
LIMITATIONS:
The study population was predominantly Caucasian, which limited the generalisability of the findings to other populations and ethnic minorities. Information on diet was not collected; hence, the potential influence of nutritional factors on glucocorticoid metabolism could not be assessed. This study could not show whether elevated hair glucocorticoid levels caused MetS due to its cross-sectional design.
DISCLOSURES:
This study was supported by Stress in Action, a research project financially supported by the Dutch Research Council and the Dutch Ministry of Education, Culture and Science. The authors declared having no conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Food Texture Can Slow Eating, Curb Calorie Intake From UPFs
Food texture influences the eating rate (ER) and energy intake from ultraprocessed foods (UPFs), a small randomized, controlled trial showed. Over a 14-day period, participants consuming a UPF diet with textures that reduced their ER had an average energy intake reduction of 369 kcal/d compared to those following a 14-day UPF diet with textures that promoted a faster ER. 'The consistency of the effect of meal texture on eating rate and intake was striking,' Ciarán G. Forde, Wageningen University, Wageningen, the Netherlands, said in a press release. 'The cumulative difference in intake on average between the two diets was over 5000 kcals across the 14-day period. Almost all participants adjusted their eating behaviors in response to the meal textures served, without any guidance or instructions or the need to consciously restrict their intake or compromise on food enjoyment and satisfaction.' The study was presented at NUTRITION 2025 in Orlando, Florida. Meal Satisfaction Similar For the crossover study, 41 participants (50% men; mean age, 27 years) were randomly assigned to two 14-day diets, each with over 90% energy coming from UPFs. One diet consisted of meals and snacks with textures thought to encourage a slower eating rate (Slow-ER) and one diet consisted of textures thought to promote a faster eating rate (Fast-ER). Meals on each diet were matched for palatability, food energy density (kcal/g), portion size (grams), total energy served (kcals), and energy derived from Nova 4 (UPF) foods. On both diet arms, participants could eat as much or as little as they wanted (ad libitum) and were instructed to eat until they were comfortably full. The two diets were separated by a 14-day washout period. The daily energy intake was, on average, 369 kcal/d lower on the UPF Slow-ER diet than on the UPF Fast-ER diet. The effect on energy intake was consistent and sustained across individual participants and number of days on the diet. Meals within both diets were rated to be equally liked and familiar, and despite consuming significantly fewer calories on the Slow-ER diet, participants did not report differences in appetite sensations or meal satisfaction. There was no change in body weight pre- to post-diets and no differences in body weight between the two diets. 'Food texture-derived ER has a significant and sustained effect on energy intake of ultraprocessed diets over a 2-week period,' the authors concluded. 'This finding highlights the importance of food texture in guiding eating rate and the central role of sensory cues in regulating meal size.' Slowing Down Works In expert commentary on the study, Amanda Avery, PhD, RD, associate professor in Nutrition and Dietetics, University of Nottingham, Nottingham, England, said, 'The study reinforces the importance of people sitting down and taking time to enjoy their food. Eating foods quickly and 'on the hoof' may lead to extra energy intake, which may lead to weight gain. Ideally, we should be choosing foods with more texture, such as UPFs with more texture, but also balanced with vegetables, whole fruits, whole grain cereals, beans, legumes, lean meat, fish, so we have to chew the food.' In a separate comment, Julian Hamilton-Shield, MD, professor in Diabetes and Metabolic Endocrinology, University of Bristol, Bristol, England, said, 'This study reinforces previous epidemiological, experimental, and clinical trial data demonstrating that any maneuver to slow eating rate consistently, in this current study by meal texture, reduces an individual's total calorie intake. While it can be difficult to sustain a reduced eating speed, altering food texture [to slow] eating speed seems an attractive additional tool for population-based, weight management strategies.' Forde did not provide information on funding or potential conflicts of interest. Avery declared consulting in Nutrition, Research and Health Policy at Slimming World. Hamilton-Shield declared conducting experimental and trial studies on slowing eating speed by a different methodology, 'finding results for calorie intake in agreement with the study being described.'
Medscape
2 hours ago
- Medscape
NSAIDs May Pose Greater Heart Risks Than Colchicine in Gout
In patients with gout starting allopurinol as a long-term urate-lowering therapy, the prophylactic use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a higher risk for major adverse cardiovascular events (MACEs) than the use of colchicine or no prophylaxis. METHODOLOGY: Researchers followed a target trial framework to emulate a randomized clinical trial using data from administrative databases in British Columbia, Canada, to compare the cardiovascular safety of the prophylactic use of NSAIDs vs colchicine in patients with gout who started allopurinol between 1995 and 2022. They included 9060 patients who were prescribed NSAIDs (mean age, 60.9 years; 83.5% men) who were propensity score-matched with 9060 patients prescribed colchicine on the same day as allopurinol. The primary outcome was MACE, a composite of myocardial infarction, ischemic stroke, or cardiovascular death. Secondary outcomes included the individual components of MACE and all-cause mortality. Sensitivity analyses were also conducted with follow-up truncated after 3 months or 6 months and using inverse probability treatment weighting. Additionally, the cardiovascular safety of NSAIDs and colchicine was compared with that of no prophylaxis after propensity matching. TAKEAWAY: The risk for MACE was higher in patients using NSAIDs than in those using colchicine (hazard ratio [HR], 1.56; 95% CI, 1.11-2.17). Findings were consistent in sensitivity analyses. The use of NSAIDs was associated with significantly higher risks for cardiovascular death (HR, 2.50; 95% CI, 1.14-5.26) and all-cause mortality (HR, 2.00; 95% CI, 1.19-3.45) than the use of colchicine. Compared with no prophylaxis, the use of NSAIDs was associated with a 50% higher risk for MACE (HR, 1.50; 95% CI, 1.17-1.91) and a 93% higher risk for myocardial infarction (HR, 1.93; 95% CI, 1.35-2.75), whereas the use of colchicine was not associated with risk for MACE or its individual components. IN PRACTICE: 'The findings of this present study have the potential to impact clinical care as well as current guidelines, as they highlight the real potential dangers of NSAID use, even short-term, among patients with gout and provide additional evidence in support of colchicine as the preferred paradoxical gout flare prophylaxis agent,' the authors wrote. SOURCE: This study was led by Chio Yokose, MD, MSc, Massachusetts General Hospital, Boston. It was published online on May 26, 2025, in Arthritis & Rheumatology . LIMITATIONS: The risk for residual confounding factors remained owing to the observational nature of this study. Data on key cardiovascular risk factors such as use of tobacco, BMI, or lipid panel were unavailable. Cardiovascular risk associated with different types of NSAID was not analyzed. DISCLOSURES: Some authors reported receiving support from the National Institutes of Health and the Canadian Institutes of Health Research. Several authors reported receiving personal fees, consulting fees, royalties, and grants, and having board positions and other financial ties with multiple pharmaceutical and healthcare companies.
Yahoo
2 hours ago
- Yahoo
Childhood trauma linked to higher risk of endometriosis in adult women
ST. PAUL, Minn., June 11 (UPI) -- A suspected link between childhood trauma and the risk of developing endometriosis in later life was strengthened Wednesday with the publication of study that showed a greater chance of the condition among women with histories of difficult childhoods. The study of hundreds of thousands of women in Sweden found those who as children experienced substance abuse, had a teenage or mentally ill parent, financial problems or a death in the family were linked to a 20% increased risk of an endometriosis diagnosis compared to women who had not been exposed. However, the risk was much greater for girls exposed more than one of those factors, rising to 60%, while those who witnessed or were subjected to violence saw more than twice the risk of developing endometriosis later in life compared to women who had not been exposed, the Swedish authors reported. The study published in the British medical journal Human Reproduction builds on earlier findings that women who experienced physical and sexual abuse as children had a 79% higher risk of developing the painful condition, which affects one in 10 reproductive-age women in the United States. Lead author Dr. Marika Rostvall, a physician and doctoral student in the Department of Global Public Health at the Karolinska Institute in Stockholm, told UPI the findings provide more evidence of the strong connection between mental and physical health. The findings "support previous studies in other areas of medicine suggesting that the mind and body are intimately connected and that psychologically taxing events can have biological consequences," she said in emailed comments. Endometriosis usually affects women in their 20s and 30s, and while there are a handful known risk factors such as starting menstruation early and having a lean body type, the cause remains unknown. The problems stem from the behavior of tissues known as endometrium, which under normal circumstances are found only in the inner lining of a woman's uterus. Those tissues grow to a thick, blood vessel-rich layer during the menstrual cycle to prepare for possible implantation of an embryo, and then shed the blood at the end of the cycle if there is no embryo present. But in some cases, endometrium behave abnormally and start growing outside of the uterus. When they do so, they can attach themselves to the ovaries, fallopian tubes, bowel, bladder or other parts of the body, triggering frequently severe pelvic pain as they carry out their monthly thickening function. As a result, endometriosis can cause excessive bleeding and even infertility -- which is the case for up to half of women with the condition -- as well as cysts, scar tissue and adhesions. Those in turn can trigger chronic pain, including during with sexual intercourse as well as during urination or bowel movements. The Swedish researchers began by looking at the health records of more 1.3 million women born in in the country between 1974 and 2001, eventually narrowing it down to 24,000 who were diagnosed with endometriosis. They then tapped several national registers to track their childhood experiences, looking for evidence of trauma or difficulties, including crimes such as violence and sexual abuse. The results, they said, demonstrate the importance of considering "the whole person" not just the symptoms of endometriosis. The negative physical consequences of psychological trauma can perhaps be traced to a compromised ability of the immune system to protect against the condition, or even in how the body perceives pain, Rostvall said. "I think the immune system is an interesting part of the puzzle when it comes to trying to understand why some women develop endometriosis," she said. "Chronic inflammation is a big part of the disease, and it has also been shown that women with endometriosis have a higher incidence of autoimmune disorders compared to healthy women. "There is a lot of interesting research being done in the area, and a deeper understanding of exactly how the immune system functions in relation to endometriosis could potentially help bring forward new kinds of treatment." Like some other women's health issues, the pain of endometriosis is often dismissed and sufferers have reported negative experiences with healthcare professionals, often in the form of providers "trivializing" symptoms, which can cause feelings of loneliness and alienation. This, in turn, can make obtaining a diagnosis difficult and prompt some to choose to avoid engaging with doctors altogether. A British psychological-based study from last year showed some women who suffered symptoms felt they had experienced a form of "medical gaslighting" in which they were made to doubt their own perceptions of pain. Rostvall said these kinds of experiences are especially relevant when the patients are women who come from socially and psychologically traumatic backgrounds. "A lot of women presenting with pain, especially socioeconomically disadvantaged women and women with psychiatric comorbidities, who are more likely to have experienced childhood adversity, have their pain dismissed. They then have to wait for a long time to receive a diagnosis and treatment, potentially allowing the condition to worsen," she said. "I think physicians should be aware of the complex linkage between the mind and body in general and be more open to listening to their patients' stories, take their pain seriously, and offer a thorough physical examination."
